RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice

Neuron

Volumn 37, Issue 3, 2003, Pages 417-431

  Miyashiro, Kevin Y ^a   Beckel Mitchener, Andrea ^a   Purk, T Patrick ^b   Becker, Kevin G ^c   Barret, Tanya ^c   Liu, Lei ^b   Carbonetto, Salvatore ^d   Weiler, Ivan Jeanne ^b   Greenough, William T ^b   Eberwine, James ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA; RIBONUCLEOPROTEIN; RNA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELL FUNCTION; CONTROLLED STUDY; CROSS LINKING; GENETIC CODE; KNOCKOUT MOUSE; MENTAL DEFICIENCY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RNA BINDING; SIGNAL TRANSDUCTION; ULTRAVIOLET RADIATION;

EID: 0037421721     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(03)00034-5     Document Type: Article

References (56)

1. Ashley C.T. Jr., Wilkinson K.D., Reines D., Warren S.T. FMR1 protein. conserved RNP family domains and selective RNA binding Science. 262:1993;563-566.
2. Auth D., Brawerman G. A 33kDa polypeptide with homology to the laminin receptor. component of translation machinery Proc. Natl. Acad. Sci. USA. 89:1992;4368-4372.
3. Bardoni B., Sittler A., Shen Y., Mandel J.L. Analysis of domains affecting intracellular localization of the FMRP protein. Neurobiol. Dis. 4:1997;329-336.
4. Bardoni B., Schenck A., Mandel J.L. A novel RNA-binding nuclear protein that interacts with the fragile X mental retardation (FMR1) protein. Hum. Mol. Genet. 8:1999;2557-2566.
5. Brown V., Small K., Lakkis L., Feng Y., Gunter C., Wilkinson K.D., Warren S.T. Purified recombinant Fmrp exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation protein. J. Biol. Chem. 273:1998;15521-15527.
6. Brown V., Jin P., Ceman S., Darnell J.C., O'Donnell W.T., Tenenbaum S.A., Jin X., Feng Y., Wilkinson K.D., Keene J.D.et al. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell. 107:2001;477-487.
7. Buchhalter J.R., Fieles A., Dichter M.A. Hippocampal commissural connections in the neonatal rat. Brain Res. Dev. Brain Res. 56:1990;211-216.
8. Ceman S., Brown V., Warren S.T. Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X-related proteins as components of the complex. Mol. Cell. Biol. 19:1999;7925-7932.
9. Ceman S., Nelson R., Warren S.T. Identification of mouse YB1/p50 as a component of the FMRP-associated mRNP particle. Biochem. Biophys. Res. Commun. 279:2000;904-908.
10. An autosomal genomic screen for autism. Am. J. Med. Genet. 105:2001;609-615.
11. Comery T.A., Harris J.B., Willems P.J., Oostra B.A., Irwin S.A., Weiler I.J., Greenough W.T. Abnormal dendritic spines in fragile X knockout mice. maturation and pruning deficits Proc. Natl. Acad. Sci. USA. 94:1997;5401-5404.
12. Corbin F., Bouillon M., Fortin A., Morin S., Rousseau F., Khandjian E.W. The fragile X mental retardation protein is associated with poly(A)+ mRNA in actively translating polyribosomes. Hum. Mol. Genet. 6:1997;1465-1472.
13. Darnell J.C., Jensen K.B., Jin P., Brown V., Warren S.T., Darnell R.B. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell. 107:2001;489-499.
14. Dawson S., Apcher S., Mee M., Higashitsuji H., Baker R., Uhle S., Dubiel W., Fujita J., Mayer R. Gankyrin is an ankyrin-repeat oncoprotein that interacts with CDK4 kinase and the S6ATPase of the 26S proteasome. J. Biol. Chem. 277:2002;10893-10902.
15. De Boulle K., Verkerk A.J., Reyniers E., Vits L., Hendrickx J., Van Roy B., Van den Bos F., de Graaff E., Oostra B.A., Willems P.J. A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat. Genet. 3:1993;31-35.
16. Devys D., Lutz Y., Rouyer N., Bellocq J.P., Mandel J.L. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat. Genet. 4:1993;335-340.
17. The Dutch-Belgian Fragile X Consortium Fmr1 knockout mice. a model to study fragile X mental retardation Cell. 78:1994;23-33.
18. Dykens E., Volkmar F.R. Medical conditions associated with autism. Second Ed., Cohen D.J., Volkmar F.R. Handbook of Autism and Pervasive Developmental Disorders. 1997;Wiley, New York. 388-410.pp.
19. Eberwine J., Kacharmina J.E., Andrews C., Miyashiro K., McIntosh T., Becker K., Barrett T., Hinkle D., Dent G., Marciano P. mRNA expression analysis of tissue sections and single cells. J. Neurosci. 21:2001;8310-8314.
20. Feinstein C., Reiss A.L. Autism. the point of view from fragile X studies J. Autism Dev. Disord. 28:1998;395-402.
21. Hagerman R.J., Sobesky W.E. Psychopathology in fragile X syndrome. Am. J. Orthopsychiatry. 59:1989;142-152.
22. Hessl D., Glaser B., Dyer-Friedman J., Blasey C., Hastie T., Gunnar M., Reiss A. Cortisol and behavior in fragile X syndrome. Psychoneuroendocrinology. 27:2002;855-872.
23. International Molecular Genetic Study of Autism Consortium A genomewide screen for autism. strong evidence for linkage to chromosomes 2q, 7q, and 16p Am. J. Hum. Genet. 69:2001;570-581.
24. Irwin S.A., Swain R.A., Christmon C.A., Chakravarti A., Weiler I.J., Greenough W.T. Evidence for altered Fragile-X mental retardation protein expression in response to behavioral stimulation. Neurobiol. Learn. Mem. 74:2000;87-93.
25. Joels M.J. Corticosteroid actions in the hippocampus. J. Neuroendocrinol. 13:2001;657-669.
26. Keene J.D. Ribonucleoprotein infrastructure regulating the flow of genetic information between the genome and the proteome. Proc. Natl. Acad. Sci. USA. 98:2001;7018-7024.
27. Laggerbauer B., Ostareck D., Keidel E.M., Ostareck-Lederer A., Fischer U. Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum. Mol. Genet. 10:2001;329-338.
28. Li Z., Zhang Y., Ku L., Wilkinson K.D., Warren S.T., Feng Y. The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Res. 29:2001;2276-2283.
29. Morales J., Hiesinger P.R., Schroeder A.J., Kume K., Verstreken P., Jackson F.R., Nelson D.L., Hassan B.A. Drosophila fragile X protein, dFXR, regulates neuronal morphology and function in the brain. Neuron. 34:2002;961-972.
30. Oberle I., Rousseau F., Heitz D., Kretz C., Devys D., Hanauer A., Boue J., Bertheas M.F., Mandel J.L. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science. 252:1991;1097-1102.
31. Philippe A., Martinez M., Guilloud-Bataille M., Gillberg C., Rastam M., Sponheim E., Coleman M., Zappella M., Aschauer H., Van Maldergem L.et al. Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study. Hum. Mol. Genet. 8:1999;805-812.
32. Reiss A.L., Freund L. Fragile X syndrome, DSM-III-R, and autism. J. Am. Acad. Child Adolesc. Psychiatry. 29:1990;885-891.
33. Rogers S.J., Wehner D.E., Hagerman R. The behavioral phenotype in fragile X. symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders J. Dev. Behav. Pediatr. 22:2001;409-417.
34. Roozendaal B. 1999 Curt P. Richter award. glucocorticoids and the regulation of memory consolidation Psychoneuroendocrinology. 25:2000;213-238.
35. Rudelli R.D., Brown W.T., Wisniewski K., Jenkins E.C., Laure-Kamionowska M., Connell F., Wisniewski H.M. Adult fragile X syndrome. Clinico-neuropathologic findings. Acta Neuropathol. (Berl). 67:1985;289-295.
36. Schaeffer C., Bardoni B., Mandel J.L., Ehresmann B., Ehresmann C., Moine H. The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif. EMBO J. 20:2001;4803-4813.
37. Schenck A., Bardoni B., Moro A., Bagni C., Mandel J.L. A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P. Proc. Natl. Acad. Sci. USA. 98:2001;8844-8849.
38. Shao Y., Wolpert C.M., Raiford K.L., Menold M.M., Donnelly S.L., Ravan S.A., Bass M.P., McClain C., von Wendt L., Vance J.M.et al. Genomic screen and follow-up analysis for autistic disorder. Am. J. Med. Genet. 114:2002;99-105.
39. Siomi M.C., Zhang Y., Siomi H., Dreyfuss G. Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them. Mol. Cell. Biol. 16:1996;3825-3832.
40. Sittler A., Devys D., Weber C., Mandel J.L. Alternative splicing of exon 14 determines nuclear or cytoplasmic localisation of fmr1 protein isoforms. Hum. Mol. Genet. 5:1996;95-102.
41. Sperber B.R., Leight S., Goedert M., Lee V.M. Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells. Neurosci. Lett. 197:1995;149-153.
42. Steward O., Bakker C.E., Willems P.J., Oostra B.A. No evidence for disruption of normal patterns of mRNA localization in dendrites or dendritic transport of recently synthesized mRNA in FMR1 knockout mice, a model for human fragile-X mental retardation syndrome. Neuroreport. 9:1998;477-481.
43. Sun H.T., Cohen S., Kaufmann W.E. Annexin-1 is abnormally expressed in fragile X syndrome. two-dimensional electrophoresis study in lymphocytes Am. J. Med. Genet. 103:2001;81-90.
44. Sung Y.J., Conti J., Currie J.R., Brown W.T., Denman R.B. RNAs that interact with the fragile X syndrome RNA binding protein FMRP. Biochem. Biophys. Res. Commun. 275:2000;973-980.
45. Tamanini F., Willemsen R., van Unen L., Bontekoe C., Galjaard H., Oostra B.A., Hoogeveen A.T. Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis. Hum. Mol. Genet. 6:1997;1315-1322.
46. Tamanini F., Van Unen L., Bakker C., Sacchi N., Galjaard H., Oostra B.A., Hoogeveen A.T. Oligomerization properties of fragile-X mental-retardation protein (FMRP) and the fragile-X-related proteins FXR1P and FXR2P. Biochem. J. 343:1999;517-523.
47. Tecott L.H., Barchas J.D., Eberwine J.H. In situ transcription. specific synthesis of complementary DNA in fixed tissue sections Science. 240:1988;661-664.
48. Tenenbaum S.A., Carson C.C., Lager P.J., Keene J.D. Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays. Proc. Natl. Acad. Sci. USA. 97:2000;14085-14090.
49. Trifillis P., Day N., Kiledjian M. Finding the right RNA. identification of cellular mRNA substrates for RNA-binding proteins RNA. 5:1999;1071-1082.
50. Turner G., Webb T., Wake S., Robinson H. Prevalence of fragile X syndrome. Am. J. Med. Genet. 64:1996;196-197.
51. Warren S.T., Nelson D.L. Advances in molecular analysis of fragile X syndrome. JAMA. 271:1994;536-542.
52. Weiler I.J., Irwin S.A., Klintsova A.Y., Spencer C.M., Brazelton A.D., Miyashiro K., Comery T.A., Patel B., Eberwine J., Greenough W.T. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc. Natl. Acad. Sci. USA. 94:1997;5395-5400.
53. Wisbeck J.M., Huffman L.C., Freund L., Gunnar M.R., Davis E.P., Reiss A.L. Cortisol and social stressors in children with fragile X. a pilot study J. Dev. Behav. Pediatr. 21:2000;278-282.
54. Zhang Y., O'Connor J.P., Siomi M.C., Srinivasan S., Dutra A., Nussbaum R.L., Dreyfuss G. The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. EMBO J. 14:1995;5358-5366.
55. Zhang Y.Q., Bailey A.M., Matthies H.J., Renden R.B., Smith M.A., Speese S.D., Rubin G.M., Broadie K. Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell. 107:2001;591-603. a.
56. Zhang H.T., Kacharmina J.E., Miyashiro K., Greene M.I., Eberwine J. Protein quantification from complex protein mixtures using a proteomics methodology with single-cell resolution. Proc. Natl. Acad. Sci. USA. 98:2001;5497-5502. b.